116 related articles for article (PubMed ID: 29165413)
1. [Ophthalmoferon efficacy in the treatment of children with chronic blepharoconjunctivitis].
Prozornaya LP; Brzheskiy VV
Vestn Oftalmol; 2017; 133(5):49-55. PubMed ID: 29165413
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of chronic allergic blepharoconjunctivitis].
Ianchenko SV; Sakhnov SN; Malyshev AV; Fedotova NV; Orekhova OIu; Grishchenko IV
Vestn Oftalmol; 2014; 130(5):78, 80-4. PubMed ID: 25711068
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis.
Torkildsen GL; Cockrum P; Meier E; Hammonds WM; Silverstein B; Silverstein S
Curr Med Res Opin; 2011 Jan; 27(1):171-8. PubMed ID: 21138337
[TBL] [Abstract][Full Text] [Related]
4. [Demodicidosis in a female patient treated as allergic blepharoconjunctivitis. A case report].
Morfin Maciel BM
Rev Alerg Mex; 2003; 50(6):232-6. PubMed ID: 14968988
[TBL] [Abstract][Full Text] [Related]
5. [. Oсumethyl in the treatment of allergic diseases of eyelids and conjunctiva].
Marchenko NR
Vestn Oftalmol; 2016; 132(5):81-85. PubMed ID: 27911431
[TBL] [Abstract][Full Text] [Related]
6. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
[TBL] [Abstract][Full Text] [Related]
7. [Eye lid hygiene in chronic allergic blepharoconjunctivitis patients before laser refractive surgery].
Yanchenko SV; Malyshev AV; Sakhnov SN; Fedotova NV; Orekhova OY
Vestn Oftalmol; 2016; 132(5):86-92. PubMed ID: 27911432
[TBL] [Abstract][Full Text] [Related]
8. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study.
Virtanen HM; Reitamo S; Kari M; Kari O
Acta Ophthalmol Scand; 2006 Oct; 84(5):693-5. PubMed ID: 16965503
[TBL] [Abstract][Full Text] [Related]
9. [Topical administration of metronidazole gel as an effective therapy alternative in chronic Demodex blepharitis--a case report].
Junk AK; Lukacs A; Kampik A
Klin Monbl Augenheilkd; 1998 Jul; 213(1):48-50. PubMed ID: 9743939
[TBL] [Abstract][Full Text] [Related]
10. Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis.
Williams JI; Kennedy KS; Gow JA; Torkildsen GL; Abelson MB; Gomes PJ; McNamara TR;
J Ocul Pharmacol Ther; 2011 Aug; 27(4):385-93. PubMed ID: 21649522
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: a double-masked, environmental study of patient preference.
Leonardi A; Zafirakis P
Curr Med Res Opin; 2004 Aug; 20(8):1167-73. PubMed ID: 15324519
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
Avunduk AM; Tekelioglu Y; Turk A; Akyol N
Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
[TBL] [Abstract][Full Text] [Related]
13. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
Adefule-Ositelu AO; Onakoya AO; Olasimbo OO; Adefule AK
Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377
[TBL] [Abstract][Full Text] [Related]
14. Multicenter clinical evaluation of bepotastine besilate ophthalmic solutions 1.0% and 1.5% to treat allergic conjunctivitis.
Macejko TT; Bergmann MT; Williams JI; Gow JA; Gomes PJ; McNamara TR; Abelson MB;
Am J Ophthalmol; 2010 Jul; 150(1):122-127.e5. PubMed ID: 20488431
[TBL] [Abstract][Full Text] [Related]
15. Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis.
Haque RM; Torkildsen GL; Brubaker K; Zink RC; Kowalski RP; Mah FS; Pflugfelder SC
Cornea; 2010 Aug; 29(8):871-7. PubMed ID: 20508503
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin A inhibits eosinophilic infiltration into the conjunctiva mediated by type IV allergic reactions.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Liu FT; Ueno H
Clin Exp Ophthalmol; 2006; 34(4):347-53. PubMed ID: 16764655
[TBL] [Abstract][Full Text] [Related]
17. [Blepharitis. Demodex folliculorum, associated pathogen spectrum and specific therapy].
Demmler M; de Kaspar HM; Möhring C; Klauss V
Ophthalmologe; 1997 Mar; 94(3):191-6. PubMed ID: 9181834
[TBL] [Abstract][Full Text] [Related]
18. Ocular demodicosis as a potential cause of pediatric blepharoconjunctivitis.
Liang L; Safran S; Gao Y; Sheha H; Raju VK; Tseng SC
Cornea; 2010 Dec; 29(12):1386-91. PubMed ID: 20847679
[TBL] [Abstract][Full Text] [Related]
19. Treatment of refractory atopic blepharoconjunctivitis with topical tacrolimus 0.03% dermatologic ointment.
Sakarya Y; Sakarya R
J Ocul Pharmacol Ther; 2012 Feb; 28(1):94-6. PubMed ID: 22103968
[TBL] [Abstract][Full Text] [Related]
20. [The use of the medicine Ophtalmoferon for the treatment of conjunctivitis in patients with HIV-infection and tuberculosis].
Mordyk AV; Bagisheva NV; Nebesnaya EY; Khlebova NV; Sitnikova SV; Nesterova KI; Trukhan DI; Moiseeva MV
Vestn Oftalmol; 2021; 137(4):82-89. PubMed ID: 34410061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
